Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Clinical trial NCT01342926 · COMPLETED
Trial details
- NCT number
- NCT01342926
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2016-04-01
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.